Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin

被引:32
作者
Fendukly, F
Karlsson, I
Hanson, HS
Kronvall, G
Dornbusch, K
机构
[1] Karolinska Hosp & Inst, Clin Microbiol MTC, Stockholm, Sweden
[2] St Gorans Univ Hosp, Stockholm, Sweden
关键词
quinolone-resistance determining region (QRDR); target genes; gyrase; topoisomerase; susceptibility tests;
D O I
10.1034/j.1600-0463.2003.1110904.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thirty-two Escherichia coli and 21 Klebsiella pneumoniae septicemia isolates with varying degrees of resistance to ciprofloxacin were analyzed for the presence of point mutations within the quinolone-resistance target genes. The number of mutations observed in the resistant isolates agreed with the level of ciprofloxacin resistance in both species. Such isolates were also resistant to nalidixic acid. Isolates with borderline susceptibility to ciprofloxacin, on the other hand, behaved differently in the two species. In E coli all the isolates harbored at least one mutation and these isolates were also resistant to nalidixic acid, while no mutations were detected in the K pneumoniae isolates, and susceptibility to nalidixic acid was unpredictable. Therefore, nalidixic acid cannot be used as a class representative. Time-kill curve studies on an isolate with borderline susceptibility from each species showed higher degrees of resistance to ciprofloxacin in comparison to that of the wild-type E coli. A previously unreported parC mutation, S57-->T, was detected in a resistant E coli isolate and might expand the QRDR of this gene. Normalized resistance interpretations of histograms confirmed the setting of microbiological zone breakpoints for ciprofloxacin testing.
引用
收藏
页码:857 / 866
页数:10
相关论文
共 23 条
[1]   Interaction between DNA gyrase and quinolones:: Effects of alanine mutations at GyrA subunit residues Ser83 and Asp87 [J].
Barnard, FM ;
Maxwell, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :1994-2000
[2]   NOVEL GYRA POINT MUTATION IN A STRAIN OF ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES BUT NOT TO NALIDIXIC-ACID [J].
CAMBAU, E ;
BORDON, F ;
COLLATZ, E ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1247-1252
[3]   gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli [J].
Conrad, S ;
Oethinger, M ;
Kaifel, K ;
Klotz, G ;
Marre, R ;
Kern, WV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) :443-455
[4]   In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections [J].
Deguchi, T ;
Kawamura, T ;
Yasuda, M ;
Nakano, M ;
Fukuda, H ;
Kato, H ;
Kato, N ;
Okano, Y ;
Kawada, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1609-1611
[5]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[6]   Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].
Everett, MJ ;
Jin, YF ;
Ricci, V ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386
[7]   Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region [J].
Friedman, SM ;
Lu, T ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2378-2380
[8]   Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands [J].
Goettsch, W ;
van Pelt, W ;
Nagelkerke, N ;
Hendrix, MGR ;
Buiting, AGM ;
Petit, PL ;
Sabbe, LJM ;
van Griethuysen, AJA ;
de Neeling, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :223-228
[10]  
HOOPER CD, 1991, ANTIBIOTICS LAB MED